Chromosome engineering and CRISPR-Cas9 viability screening reveals increased metastatic capacity targetable by patient-specific synthetic lethality

DSpace Repository

Show simple item record

dc.contributor.author Nahnsen, Sven
dc.contributor.author Lemke, Steffen
dc.date.accessioned 2024-01-09T12:35:41Z
dc.date.available 2024-01-09T12:35:41Z
dc.date.issued 2023-06
dc.identifier.uri http://hdl.handle.net/10900/149106
dc.language.iso en de_DE
dc.publisher Elsevier de_DE
dc.relation.uri https://doi.org/10.1016/S0168-8278(23)01323-5 de_DE
dc.subject.ddc 004 de_DE
dc.title Chromosome engineering and CRISPR-Cas9 viability screening reveals increased metastatic capacity targetable by patient-specific synthetic lethality de_DE
dc.type Article de_DE
utue.personen.roh Nahnsen, Sven
utue.personen.roh Roessler, Stephanie
utue.personen.roh Schirmacher, Peter
utue.personen.roh Marquardt, Jens U.
utue.personen.roh Goeppert, Benjamin
utue.personen.roh Albrecht, Thomas
utue.personen.roh Pusch, Stefan
utue.personen.roh Jauch, Anna
utue.personen.roh Eiteneuer, Eva
utue.personen.roh Sticht, Carsten
utue.personen.roh Ibberson, David
utue.personen.roh Castven, Darko
utue.personen.roh Sugiyanto, Raisatun N.
utue.personen.roh Fritzsche, Sarah
utue.personen.roh Lemke, Steffen
utue.personen.roh Dreher, Emely
utue.personen.roh Huth, Thorben
dcterms.isPartOf.ZSTitelID POSTER PRESENTATIONS: LIVER TUMOURS EXPERIMENTAL AND PATHOPHYSIOLOGY de_DE


Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record